nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—ADRA1A—hypertension	0.19	1	CbGaD
Phenylephrine—Salbutamol—Nadolol—hypertension	0.0623	0.235	CrCrCtD
Phenylephrine—Norepinephrine—Methyldopa—hypertension	0.06	0.226	CrCrCtD
Phenylephrine—Epinephrine—Methyldopa—hypertension	0.0454	0.171	CrCrCtD
Phenylephrine—Isoprenaline—Methyldopa—hypertension	0.0369	0.139	CrCrCtD
Phenylephrine—Isoprenaline—Pindolol—hypertension	0.0321	0.121	CrCrCtD
Phenylephrine—Isoprenaline—Labetalol—hypertension	0.0285	0.107	CrCrCtD
Phenylephrine—ADRA1D—Terazosin—hypertension	0.0249	0.0722	CbGbCtD
Phenylephrine—ADRA1D—Fenoldopam—hypertension	0.0225	0.0653	CbGbCtD
Phenylephrine—ADRA1D—Doxazosin—hypertension	0.0207	0.0603	CbGbCtD
Phenylephrine—ADRA1B—Terazosin—hypertension	0.0181	0.0526	CbGbCtD
Phenylephrine—ADRA1D—Prazosin—hypertension	0.017	0.0495	CbGbCtD
Phenylephrine—ADRA1B—Fenoldopam—hypertension	0.0164	0.0476	CbGbCtD
Phenylephrine—ADRA1B—Doxazosin—hypertension	0.0151	0.0439	CbGbCtD
Phenylephrine—ADRA1D—Nicardipine—hypertension	0.0147	0.0427	CbGbCtD
Phenylephrine—ADRA1D—Carvedilol—hypertension	0.0147	0.0427	CbGbCtD
Phenylephrine—ADRA1A—Terazosin—hypertension	0.0143	0.0415	CbGbCtD
Phenylephrine—ADRA1A—Fenoldopam—hypertension	0.0129	0.0375	CbGbCtD
Phenylephrine—ADRA1D—Clonidine—hypertension	0.0129	0.0375	CbGbCtD
Phenylephrine—ADRA1B—Prazosin—hypertension	0.0124	0.036	CbGbCtD
Phenylephrine—ADRA1A—Doxazosin—hypertension	0.0119	0.0346	CbGbCtD
Phenylephrine—ADRA1B—Nicardipine—hypertension	0.0107	0.0311	CbGbCtD
Phenylephrine—ADRA1B—Carvedilol—hypertension	0.0107	0.0311	CbGbCtD
Phenylephrine—ADRA1A—Prazosin—hypertension	0.00979	0.0284	CbGbCtD
Phenylephrine—ADRA1B—Clonidine—hypertension	0.0094	0.0273	CbGbCtD
Phenylephrine—ADRA1A—Carvedilol—hypertension	0.00845	0.0245	CbGbCtD
Phenylephrine—ADRA1A—Nicardipine—hypertension	0.00845	0.0245	CbGbCtD
Phenylephrine—ADRA1B—vas deferens—hypertension	0.00814	0.43	CbGeAlD
Phenylephrine—ADRA1A—Clonidine—hypertension	0.00742	0.0216	CbGbCtD
Phenylephrine—CYP1A2—Guanabenz—hypertension	0.00688	0.02	CbGbCtD
Phenylephrine—CYP1A2—Triamterene—hypertension	0.00688	0.02	CbGbCtD
Phenylephrine—CYP1A2—Betaxolol—hypertension	0.0057	0.0166	CbGbCtD
Phenylephrine—CYP1A2—Nisoldipine—hypertension	0.00502	0.0146	CbGbCtD
Phenylephrine—CYP1A2—Irbesartan—hypertension	0.00395	0.0115	CbGbCtD
Phenylephrine—CYP1A2—Amlodipine—hypertension	0.00387	0.0113	CbGbCtD
Phenylephrine—CYP1A2—Nifedipine—hypertension	0.00361	0.0105	CbGbCtD
Phenylephrine—CYP1A2—Carvedilol—hypertension	0.00356	0.0103	CbGbCtD
Phenylephrine—CYP1A2—Propranolol—hypertension	0.00327	0.00951	CbGbCtD
Phenylephrine—CYP1A2—Clonidine—hypertension	0.00312	0.00907	CbGbCtD
Phenylephrine—MAOA—locus ceruleus—hypertension	0.0026	0.137	CbGeAlD
Phenylephrine—CYP1A2—Losartan—hypertension	0.00255	0.0074	CbGbCtD
Phenylephrine—CYP1A2—Verapamil—hypertension	0.00225	0.00653	CbGbCtD
Phenylephrine—CYP1A2—urine—hypertension	0.000941	0.0497	CbGeAlD
Phenylephrine—ADRA1B—kidney—hypertension	0.000479	0.0253	CbGeAlD
Phenylephrine—MAOA—cardiac ventricle—hypertension	0.00044	0.0232	CbGeAlD
Phenylephrine—MAOA—myocardium—hypertension	0.000414	0.0219	CbGeAlD
Phenylephrine—Isoprenaline—PIK3R1—hypertension	0.000359	0.122	CrCbGaD
Phenylephrine—ADRA1A—brainstem—hypertension	0.000337	0.0178	CbGeAlD
Phenylephrine—MAOA—brainstem—hypertension	0.000334	0.0176	CbGeAlD
Phenylephrine—ADRA1D—endocrine gland—hypertension	0.000329	0.0173	CbGeAlD
Phenylephrine—MAOA—nephron tubule—hypertension	0.000304	0.016	CbGeAlD
Phenylephrine—ADRA1B—central nervous system—hypertension	0.000303	0.016	CbGeAlD
Phenylephrine—MAOA—adrenal cortex—hypertension	0.000299	0.0158	CbGeAlD
Phenylephrine—ADRA1D—central nervous system—hypertension	0.000296	0.0156	CbGeAlD
Phenylephrine—ADRA1A—heart—hypertension	0.000292	0.0154	CbGeAlD
Phenylephrine—MAOA—heart—hypertension	0.000289	0.0153	CbGeAlD
Phenylephrine—Metaraminol—ADRA1A—hypertension	0.000286	0.0966	CrCbGaD
Phenylephrine—MAOA—decidua—hypertension	0.000281	0.0148	CbGeAlD
Phenylephrine—ADRA1A—cardiovascular system—hypertension	0.000275	0.0145	CbGeAlD
Phenylephrine—MAOA—cardiovascular system—hypertension	0.000273	0.0144	CbGeAlD
Phenylephrine—MAOA—kidney—hypertension	0.000267	0.0141	CbGeAlD
Phenylephrine—MAOA—cortex of kidney—hypertension	0.00026	0.0137	CbGeAlD
Phenylephrine—Isoprenaline—ADRBK1—hypertension	0.00026	0.0878	CrCbGaD
Phenylephrine—MAOA—cardiac atrium—hypertension	0.000247	0.013	CbGeAlD
Phenylephrine—MAOA—medulla oblongata—hypertension	0.000233	0.0123	CbGeAlD
Phenylephrine—Epinephrine—ADRBK1—hypertension	0.000218	0.0738	CrCbGaD
Phenylephrine—ADRA1A—adrenal gland—hypertension	0.000218	0.0115	CbGeAlD
Phenylephrine—MAOA—adrenal gland—hypertension	0.000216	0.0114	CbGeAlD
Phenylephrine—Tapentadol—SLC6A2—hypertension	0.000215	0.0727	CrCbGaD
Phenylephrine—ADRA1A—endocrine gland—hypertension	0.000189	0.00996	CbGeAlD
Phenylephrine—Orciprenaline—ADRB2—hypertension	0.000188	0.0635	CrCbGaD
Phenylephrine—MAOA—endocrine gland—hypertension	0.000187	0.00987	CbGeAlD
Phenylephrine—ADRA1A—central nervous system—hypertension	0.00017	0.00898	CbGeAlD
Phenylephrine—MAOA—central nervous system—hypertension	0.000169	0.0089	CbGeAlD
Phenylephrine—CYP1A2—endocrine gland—hypertension	0.000156	0.00824	CbGeAlD
Phenylephrine—Norepinephrine—ADRA2B—hypertension	0.000124	0.042	CrCbGaD
Phenylephrine—Terbutaline—ADRB2—hypertension	0.000123	0.0418	CrCbGaD
Phenylephrine—Epinephrine—ADRA2B—hypertension	0.000113	0.0381	CrCbGaD
Phenylephrine—Salbutamol—ADRB1—hypertension	0.000109	0.0369	CrCbGaD
Phenylephrine—Norepinephrine—SLC6A2—hypertension	0.000109	0.0369	CrCbGaD
Phenylephrine—Salbutamol—ADRB2—hypertension	9.18e-05	0.031	CrCbGaD
Phenylephrine—Tapentadol—SLC6A4—hypertension	8.18e-05	0.0277	CrCbGaD
Phenylephrine—Norepinephrine—ADRA1A—hypertension	7.68e-05	0.026	CrCbGaD
Phenylephrine—Epinephrine—ADRA1A—hypertension	6.97e-05	0.0236	CrCbGaD
Phenylephrine—Isoprenaline—ADRB1—hypertension	5.87e-05	0.0198	CrCbGaD
Phenylephrine—Norepinephrine—ADRA2A—hypertension	5.44e-05	0.0184	CrCbGaD
Phenylephrine—Norepinephrine—ADRB1—hypertension	5.43e-05	0.0184	CrCbGaD
Phenylephrine—Epinephrine—ADRA2A—hypertension	4.94e-05	0.0167	CrCbGaD
Phenylephrine—Isoprenaline—ADRB2—hypertension	4.94e-05	0.0167	CrCbGaD
Phenylephrine—Epinephrine—ADRB1—hypertension	4.93e-05	0.0167	CrCbGaD
Phenylephrine—Epinephrine—TNF—hypertension	4.68e-05	0.0158	CrCbGaD
Phenylephrine—Norepinephrine—ADRB2—hypertension	4.57e-05	0.0155	CrCbGaD
Phenylephrine—Isoprenaline—CYP1A1—hypertension	4.23e-05	0.0143	CrCbGaD
Phenylephrine—Epinephrine—ADRB2—hypertension	4.15e-05	0.014	CrCbGaD
Phenylephrine—Norepinephrine—DRD2—hypertension	4.13e-05	0.014	CrCbGaD
Phenylephrine—Tension—Lisinopril—hypertension	2.87e-05	0.000257	CcSEcCtD
Phenylephrine—Nausea—Guanabenz—hypertension	2.87e-05	0.000257	CcSEcCtD
Phenylephrine—Nausea—Metoprolol—hypertension	2.87e-05	0.000257	CcSEcCtD
Phenylephrine—Dysgeusia—Lisinopril—hypertension	2.87e-05	0.000257	CcSEcCtD
Phenylephrine—Paraesthesia—Furosemide—hypertension	2.86e-05	0.000256	CcSEcCtD
Phenylephrine—Palpitations—Ramipril—hypertension	2.85e-05	0.000256	CcSEcCtD
Phenylephrine—Nervousness—Lisinopril—hypertension	2.85e-05	0.000255	CcSEcCtD
Phenylephrine—Dizziness—Indapamide—hypertension	2.84e-05	0.000254	CcSEcCtD
Phenylephrine—Dizziness—Diltiazem—hypertension	2.84e-05	0.000254	CcSEcCtD
Phenylephrine—Loss of consciousness—Ramipril—hypertension	2.84e-05	0.000254	CcSEcCtD
Phenylephrine—Paraesthesia—Betaxolol—hypertension	2.83e-05	0.000254	CcSEcCtD
Phenylephrine—Syncope—Timolol—hypertension	2.83e-05	0.000254	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Perindopril—hypertension	2.83e-05	0.000253	CcSEcCtD
Phenylephrine—Vomiting—Propranolol—hypertension	2.82e-05	0.000253	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Irbesartan—hypertension	2.82e-05	0.000253	CcSEcCtD
Phenylephrine—Dizziness—Carvedilol—hypertension	2.81e-05	0.000252	CcSEcCtD
Phenylephrine—Dyspnoea—Betaxolol—hypertension	2.81e-05	0.000252	CcSEcCtD
Phenylephrine—Urticaria—Trandolapril—hypertension	2.81e-05	0.000251	CcSEcCtD
Phenylephrine—Pain—Perindopril—hypertension	2.8e-05	0.000251	CcSEcCtD
Phenylephrine—Hypersensitivity—Valsartan—hypertension	2.8e-05	0.000251	CcSEcCtD
Phenylephrine—Rash—Propranolol—hypertension	2.8e-05	0.000251	CcSEcCtD
Phenylephrine—Urticaria—Enalapril—hypertension	2.8e-05	0.00025	CcSEcCtD
Phenylephrine—Dermatitis—Propranolol—hypertension	2.8e-05	0.00025	CcSEcCtD
Phenylephrine—Pain—Irbesartan—hypertension	2.79e-05	0.00025	CcSEcCtD
Phenylephrine—Palpitations—Timolol—hypertension	2.79e-05	0.00025	CcSEcCtD
Phenylephrine—Dizziness—Doxazosin—hypertension	2.78e-05	0.000249	CcSEcCtD
Phenylephrine—Loss of consciousness—Timolol—hypertension	2.78e-05	0.000248	CcSEcCtD
Phenylephrine—Pain—Hydrochlorothiazide—hypertension	2.77e-05	0.000248	CcSEcCtD
Phenylephrine—Vision blurred—Lisinopril—hypertension	2.76e-05	0.000247	CcSEcCtD
Phenylephrine—Paraesthesia—Losartan—hypertension	2.76e-05	0.000247	CcSEcCtD
Phenylephrine—Urticaria—Telmisartan—hypertension	2.76e-05	0.000247	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Furosemide—hypertension	2.75e-05	0.000246	CcSEcCtD
Phenylephrine—Chest pain—Ramipril—hypertension	2.75e-05	0.000246	CcSEcCtD
Phenylephrine—Dizziness—Fosinopril—hypertension	2.75e-05	0.000246	CcSEcCtD
Phenylephrine—Tremor—Lisinopril—hypertension	2.74e-05	0.000246	CcSEcCtD
Phenylephrine—Dyspnoea—Losartan—hypertension	2.74e-05	0.000245	CcSEcCtD
Phenylephrine—Dizziness—Eplerenone—hypertension	2.73e-05	0.000245	CcSEcCtD
Phenylephrine—Vomiting—Diltiazem—hypertension	2.73e-05	0.000245	CcSEcCtD
Phenylephrine—Vomiting—Indapamide—hypertension	2.73e-05	0.000245	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	2.73e-05	0.000245	CcSEcCtD
Phenylephrine—Hypertension—Timolol—hypertension	2.73e-05	0.000244	CcSEcCtD
Phenylephrine—Pain—Furosemide—hypertension	2.72e-05	0.000244	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Betaxolol—hypertension	2.72e-05	0.000244	CcSEcCtD
Phenylephrine—Dizziness—Nifedipine—hypertension	2.71e-05	0.000243	CcSEcCtD
Phenylephrine—Rash—Indapamide—hypertension	2.71e-05	0.000243	CcSEcCtD
Phenylephrine—Rash—Diltiazem—hypertension	2.71e-05	0.000243	CcSEcCtD
Phenylephrine—Dermatitis—Diltiazem—hypertension	2.71e-05	0.000242	CcSEcCtD
Phenylephrine—Dermatitis—Indapamide—hypertension	2.71e-05	0.000242	CcSEcCtD
Phenylephrine—Vomiting—Carvedilol—hypertension	2.71e-05	0.000242	CcSEcCtD
Phenylephrine—Dizziness—Verapamil—hypertension	2.7e-05	0.000242	CcSEcCtD
Phenylephrine—Pain—Betaxolol—hypertension	2.7e-05	0.000242	CcSEcCtD
Phenylephrine—Headache—Diltiazem—hypertension	2.69e-05	0.000241	CcSEcCtD
Phenylephrine—Headache—Indapamide—hypertension	2.69e-05	0.000241	CcSEcCtD
Phenylephrine—Pruritus—Valsartan—hypertension	2.69e-05	0.000241	CcSEcCtD
Phenylephrine—Chest pain—Timolol—hypertension	2.69e-05	0.000241	CcSEcCtD
Phenylephrine—Rash—Carvedilol—hypertension	2.68e-05	0.00024	CcSEcCtD
Phenylephrine—Dermatitis—Carvedilol—hypertension	2.68e-05	0.00024	CcSEcCtD
Phenylephrine—Pruritus—Olmesartan—hypertension	2.68e-05	0.00024	CcSEcCtD
Phenylephrine—Vomiting—Doxazosin—hypertension	2.68e-05	0.00024	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	2.67e-05	0.000239	CcSEcCtD
Phenylephrine—Hypersensitivity—Clonidine—hypertension	2.67e-05	0.000239	CcSEcCtD
Phenylephrine—Headache—Carvedilol—hypertension	2.67e-05	0.000239	CcSEcCtD
Phenylephrine—Rash—Doxazosin—hypertension	2.65e-05	0.000238	CcSEcCtD
Phenylephrine—Dermatitis—Doxazosin—hypertension	2.65e-05	0.000237	CcSEcCtD
Phenylephrine—Vomiting—Fosinopril—hypertension	2.64e-05	0.000237	CcSEcCtD
Phenylephrine—Nausea—Propranolol—hypertension	2.64e-05	0.000236	CcSEcCtD
Phenylephrine—Headache—Doxazosin—hypertension	2.64e-05	0.000236	CcSEcCtD
Phenylephrine—Pain—Losartan—hypertension	2.63e-05	0.000235	CcSEcCtD
Phenylephrine—Syncope—Lisinopril—hypertension	2.63e-05	0.000235	CcSEcCtD
Phenylephrine—Vomiting—Eplerenone—hypertension	2.63e-05	0.000235	CcSEcCtD
Phenylephrine—Rash—Fosinopril—hypertension	2.62e-05	0.000235	CcSEcCtD
Phenylephrine—Dermatitis—Fosinopril—hypertension	2.62e-05	0.000234	CcSEcCtD
Phenylephrine—Vomiting—Nifedipine—hypertension	2.61e-05	0.000233	CcSEcCtD
Phenylephrine—Rash—Eplerenone—hypertension	2.6e-05	0.000233	CcSEcCtD
Phenylephrine—Urticaria—Perindopril—hypertension	2.6e-05	0.000233	CcSEcCtD
Phenylephrine—Headache—Fosinopril—hypertension	2.6e-05	0.000233	CcSEcCtD
Phenylephrine—Hypersensitivity—Trandolapril—hypertension	2.6e-05	0.000233	CcSEcCtD
Phenylephrine—Dermatitis—Eplerenone—hypertension	2.6e-05	0.000233	CcSEcCtD
Phenylephrine—Vomiting—Verapamil—hypertension	2.6e-05	0.000232	CcSEcCtD
Phenylephrine—Urticaria—Irbesartan—hypertension	2.6e-05	0.000232	CcSEcCtD
Phenylephrine—Shock—Ramipril—hypertension	2.59e-05	0.000232	CcSEcCtD
Phenylephrine—Hypersensitivity—Enalapril—hypertension	2.59e-05	0.000232	CcSEcCtD
Phenylephrine—Palpitations—Lisinopril—hypertension	2.59e-05	0.000232	CcSEcCtD
Phenylephrine—Headache—Eplerenone—hypertension	2.59e-05	0.000232	CcSEcCtD
Phenylephrine—Rash—Nifedipine—hypertension	2.59e-05	0.000232	CcSEcCtD
Phenylephrine—Nervous system disorder—Ramipril—hypertension	2.59e-05	0.000231	CcSEcCtD
Phenylephrine—Dermatitis—Nifedipine—hypertension	2.58e-05	0.000231	CcSEcCtD
Phenylephrine—Loss of consciousness—Lisinopril—hypertension	2.57e-05	0.000231	CcSEcCtD
Phenylephrine—Rash—Verapamil—hypertension	2.57e-05	0.000231	CcSEcCtD
Phenylephrine—Urticaria—Hydrochlorothiazide—hypertension	2.57e-05	0.00023	CcSEcCtD
Phenylephrine—Tachycardia—Ramipril—hypertension	2.57e-05	0.00023	CcSEcCtD
Phenylephrine—Dermatitis—Verapamil—hypertension	2.57e-05	0.00023	CcSEcCtD
Phenylephrine—Headache—Nifedipine—hypertension	2.57e-05	0.00023	CcSEcCtD
Phenylephrine—Pruritus—Clonidine—hypertension	2.56e-05	0.00023	CcSEcCtD
Phenylephrine—Skin disorder—Ramipril—hypertension	2.56e-05	0.000229	CcSEcCtD
Phenylephrine—Headache—Verapamil—hypertension	2.56e-05	0.000229	CcSEcCtD
Phenylephrine—Hypersensitivity—Telmisartan—hypertension	2.56e-05	0.000229	CcSEcCtD
Phenylephrine—Nausea—Indapamide—hypertension	2.55e-05	0.000228	CcSEcCtD
Phenylephrine—Nausea—Diltiazem—hypertension	2.55e-05	0.000228	CcSEcCtD
Phenylephrine—Hyperhidrosis—Ramipril—hypertension	2.55e-05	0.000228	CcSEcCtD
Phenylephrine—Shock—Timolol—hypertension	2.54e-05	0.000227	CcSEcCtD
Phenylephrine—Urticaria—Furosemide—hypertension	2.53e-05	0.000227	CcSEcCtD
Phenylephrine—Nervous system disorder—Timolol—hypertension	2.53e-05	0.000226	CcSEcCtD
Phenylephrine—Nausea—Carvedilol—hypertension	2.53e-05	0.000226	CcSEcCtD
Phenylephrine—Dizziness—Valsartan—hypertension	2.51e-05	0.000225	CcSEcCtD
Phenylephrine—Urticaria—Betaxolol—hypertension	2.51e-05	0.000224	CcSEcCtD
Phenylephrine—Skin disorder—Timolol—hypertension	2.5e-05	0.000224	CcSEcCtD
Phenylephrine—Dizziness—Olmesartan—hypertension	2.5e-05	0.000224	CcSEcCtD
Phenylephrine—Pruritus—Trandolapril—hypertension	2.5e-05	0.000224	CcSEcCtD
Phenylephrine—Nausea—Doxazosin—hypertension	2.5e-05	0.000224	CcSEcCtD
Phenylephrine—Chest pain—Lisinopril—hypertension	2.49e-05	0.000223	CcSEcCtD
Phenylephrine—Hyperhidrosis—Timolol—hypertension	2.49e-05	0.000223	CcSEcCtD
Phenylephrine—Pruritus—Enalapril—hypertension	2.49e-05	0.000223	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.48e-05	0.000222	CcSEcCtD
Phenylephrine—Nausea—Fosinopril—hypertension	2.47e-05	0.000221	CcSEcCtD
Phenylephrine—Pruritus—Telmisartan—hypertension	2.46e-05	0.00022	CcSEcCtD
Phenylephrine—Nausea—Eplerenone—hypertension	2.45e-05	0.00022	CcSEcCtD
Phenylephrine—Urticaria—Losartan—hypertension	2.44e-05	0.000219	CcSEcCtD
Phenylephrine—Nausea—Nifedipine—hypertension	2.44e-05	0.000218	CcSEcCtD
Phenylephrine—Nausea—Verapamil—hypertension	2.43e-05	0.000217	CcSEcCtD
Phenylephrine—Vomiting—Valsartan—hypertension	2.42e-05	0.000216	CcSEcCtD
Phenylephrine—Hypersensitivity—Irbesartan—hypertension	2.41e-05	0.000216	CcSEcCtD
Phenylephrine—Vomiting—Olmesartan—hypertension	2.41e-05	0.000215	CcSEcCtD
Phenylephrine—Rash—Valsartan—hypertension	2.4e-05	0.000215	CcSEcCtD
Phenylephrine—Dizziness—Clonidine—hypertension	2.4e-05	0.000215	CcSEcCtD
Phenylephrine—Dermatitis—Valsartan—hypertension	2.39e-05	0.000214	CcSEcCtD
Phenylephrine—Pruritus—Captopril—hypertension	2.39e-05	0.000214	CcSEcCtD
Phenylephrine—Hypersensitivity—Hydrochlorothiazide—hypertension	2.39e-05	0.000214	CcSEcCtD
Phenylephrine—Rash—Olmesartan—hypertension	2.39e-05	0.000214	CcSEcCtD
Phenylephrine—Dermatitis—Olmesartan—hypertension	2.38e-05	0.000213	CcSEcCtD
Phenylephrine—Headache—Valsartan—hypertension	2.38e-05	0.000213	CcSEcCtD
Phenylephrine—Headache—Olmesartan—hypertension	2.37e-05	0.000212	CcSEcCtD
Phenylephrine—Paraesthesia—Ramipril—hypertension	2.37e-05	0.000212	CcSEcCtD
Phenylephrine—Shock—Lisinopril—hypertension	2.35e-05	0.000211	CcSEcCtD
Phenylephrine—Dyspnoea—Ramipril—hypertension	2.35e-05	0.00021	CcSEcCtD
Phenylephrine—Hypersensitivity—Furosemide—hypertension	2.35e-05	0.00021	CcSEcCtD
Phenylephrine—Dizziness—Trandolapril—hypertension	2.34e-05	0.000209	CcSEcCtD
Phenylephrine—Tachycardia—Lisinopril—hypertension	2.33e-05	0.000209	CcSEcCtD
Phenylephrine—Dizziness—Enalapril—hypertension	2.33e-05	0.000208	CcSEcCtD
Phenylephrine—Hypersensitivity—Betaxolol—hypertension	2.32e-05	0.000208	CcSEcCtD
Phenylephrine—Skin disorder—Lisinopril—hypertension	2.32e-05	0.000208	CcSEcCtD
Phenylephrine—Pruritus—Perindopril—hypertension	2.32e-05	0.000208	CcSEcCtD
Phenylephrine—Paraesthesia—Timolol—hypertension	2.31e-05	0.000207	CcSEcCtD
Phenylephrine—Pruritus—Irbesartan—hypertension	2.31e-05	0.000207	CcSEcCtD
Phenylephrine—Hyperhidrosis—Lisinopril—hypertension	2.31e-05	0.000207	CcSEcCtD
Phenylephrine—Vomiting—Clonidine—hypertension	2.3e-05	0.000206	CcSEcCtD
Phenylephrine—Dyspnoea—Timolol—hypertension	2.3e-05	0.000206	CcSEcCtD
Phenylephrine—Dizziness—Telmisartan—hypertension	2.3e-05	0.000206	CcSEcCtD
Phenylephrine—Pruritus—Hydrochlorothiazide—hypertension	2.29e-05	0.000205	CcSEcCtD
Phenylephrine—Rash—Clonidine—hypertension	2.28e-05	0.000205	CcSEcCtD
Phenylephrine—Dermatitis—Clonidine—hypertension	2.28e-05	0.000204	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Ramipril—hypertension	2.28e-05	0.000204	CcSEcCtD
Phenylephrine—Headache—Clonidine—hypertension	2.27e-05	0.000203	CcSEcCtD
Phenylephrine—Hypersensitivity—Losartan—hypertension	2.27e-05	0.000203	CcSEcCtD
Phenylephrine—Nausea—Valsartan—hypertension	2.26e-05	0.000202	CcSEcCtD
Phenylephrine—Pruritus—Furosemide—hypertension	2.25e-05	0.000202	CcSEcCtD
Phenylephrine—Nausea—Olmesartan—hypertension	2.25e-05	0.000201	CcSEcCtD
Phenylephrine—Vomiting—Trandolapril—hypertension	2.25e-05	0.000201	CcSEcCtD
Phenylephrine—Vomiting—Enalapril—hypertension	2.24e-05	0.0002	CcSEcCtD
Phenylephrine—Dizziness—Captopril—hypertension	2.23e-05	0.0002	CcSEcCtD
Phenylephrine—Pruritus—Betaxolol—hypertension	2.23e-05	0.0002	CcSEcCtD
Phenylephrine—Rash—Trandolapril—hypertension	2.23e-05	0.0002	CcSEcCtD
Phenylephrine—Dermatitis—Trandolapril—hypertension	2.23e-05	0.000199	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Timolol—hypertension	2.23e-05	0.000199	CcSEcCtD
Phenylephrine—Rash—Enalapril—hypertension	2.22e-05	0.000199	CcSEcCtD
Phenylephrine—Dermatitis—Enalapril—hypertension	2.22e-05	0.000199	CcSEcCtD
Phenylephrine—Headache—Trandolapril—hypertension	2.21e-05	0.000198	CcSEcCtD
Phenylephrine—Vomiting—Telmisartan—hypertension	2.21e-05	0.000198	CcSEcCtD
Phenylephrine—Headache—Enalapril—hypertension	2.21e-05	0.000197	CcSEcCtD
Phenylephrine—Pain—Timolol—hypertension	2.2e-05	0.000197	CcSEcCtD
Phenylephrine—Rash—Telmisartan—hypertension	2.19e-05	0.000196	CcSEcCtD
Phenylephrine—Dermatitis—Telmisartan—hypertension	2.19e-05	0.000196	CcSEcCtD
Phenylephrine—Pruritus—Losartan—hypertension	2.18e-05	0.000195	CcSEcCtD
Phenylephrine—Headache—Telmisartan—hypertension	2.17e-05	0.000195	CcSEcCtD
Phenylephrine—Dizziness—Perindopril—hypertension	2.17e-05	0.000194	CcSEcCtD
Phenylephrine—Dizziness—Irbesartan—hypertension	2.16e-05	0.000193	CcSEcCtD
Phenylephrine—Nausea—Clonidine—hypertension	2.15e-05	0.000193	CcSEcCtD
Phenylephrine—Paraesthesia—Lisinopril—hypertension	2.15e-05	0.000192	CcSEcCtD
Phenylephrine—Vomiting—Captopril—hypertension	2.15e-05	0.000192	CcSEcCtD
Phenylephrine—Dizziness—Hydrochlorothiazide—hypertension	2.14e-05	0.000192	CcSEcCtD
Phenylephrine—Dyspnoea—Lisinopril—hypertension	2.13e-05	0.000191	CcSEcCtD
Phenylephrine—Rash—Captopril—hypertension	2.13e-05	0.000191	CcSEcCtD
Phenylephrine—Dermatitis—Captopril—hypertension	2.13e-05	0.00019	CcSEcCtD
Phenylephrine—Headache—Captopril—hypertension	2.11e-05	0.000189	CcSEcCtD
Phenylephrine—Dizziness—Furosemide—hypertension	2.11e-05	0.000189	CcSEcCtD
Phenylephrine—Nausea—Trandolapril—hypertension	2.1e-05	0.000188	CcSEcCtD
Phenylephrine—Urticaria—Ramipril—hypertension	2.09e-05	0.000188	CcSEcCtD
Phenylephrine—Nausea—Enalapril—hypertension	2.09e-05	0.000187	CcSEcCtD
Phenylephrine—Dizziness—Betaxolol—hypertension	2.09e-05	0.000187	CcSEcCtD
Phenylephrine—Vomiting—Perindopril—hypertension	2.08e-05	0.000187	CcSEcCtD
Phenylephrine—Vomiting—Irbesartan—hypertension	2.08e-05	0.000186	CcSEcCtD
Phenylephrine—Rash—Perindopril—hypertension	2.07e-05	0.000185	CcSEcCtD
Phenylephrine—Dermatitis—Perindopril—hypertension	2.06e-05	0.000185	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Lisinopril—hypertension	2.06e-05	0.000185	CcSEcCtD
Phenylephrine—Nausea—Telmisartan—hypertension	2.06e-05	0.000185	CcSEcCtD
Phenylephrine—Vomiting—Hydrochlorothiazide—hypertension	2.06e-05	0.000184	CcSEcCtD
Phenylephrine—Rash—Irbesartan—hypertension	2.06e-05	0.000184	CcSEcCtD
Phenylephrine—Dermatitis—Irbesartan—hypertension	2.06e-05	0.000184	CcSEcCtD
Phenylephrine—Headache—Perindopril—hypertension	2.05e-05	0.000184	CcSEcCtD
Phenylephrine—Urticaria—Timolol—hypertension	2.05e-05	0.000183	CcSEcCtD
Phenylephrine—Headache—Irbesartan—hypertension	2.05e-05	0.000183	CcSEcCtD
Phenylephrine—Pain—Lisinopril—hypertension	2.04e-05	0.000183	CcSEcCtD
Phenylephrine—Rash—Hydrochlorothiazide—hypertension	2.04e-05	0.000183	CcSEcCtD
Phenylephrine—Dermatitis—Hydrochlorothiazide—hypertension	2.04e-05	0.000183	CcSEcCtD
Phenylephrine—Dizziness—Losartan—hypertension	2.03e-05	0.000182	CcSEcCtD
Phenylephrine—Headache—Hydrochlorothiazide—hypertension	2.03e-05	0.000182	CcSEcCtD
Phenylephrine—Vomiting—Furosemide—hypertension	2.03e-05	0.000181	CcSEcCtD
Phenylephrine—Rash—Furosemide—hypertension	2.01e-05	0.00018	CcSEcCtD
Phenylephrine—Dermatitis—Furosemide—hypertension	2.01e-05	0.00018	CcSEcCtD
Phenylephrine—Vomiting—Betaxolol—hypertension	2.01e-05	0.00018	CcSEcCtD
Phenylephrine—Nausea—Captopril—hypertension	2.01e-05	0.00018	CcSEcCtD
Phenylephrine—Headache—Furosemide—hypertension	2e-05	0.000179	CcSEcCtD
Phenylephrine—Rash—Betaxolol—hypertension	1.99e-05	0.000178	CcSEcCtD
Phenylephrine—Dermatitis—Betaxolol—hypertension	1.99e-05	0.000178	CcSEcCtD
Phenylephrine—Headache—Betaxolol—hypertension	1.98e-05	0.000177	CcSEcCtD
Phenylephrine—Vomiting—Losartan—hypertension	1.95e-05	0.000175	CcSEcCtD
Phenylephrine—Nausea—Perindopril—hypertension	1.95e-05	0.000174	CcSEcCtD
Phenylephrine—Hypersensitivity—Ramipril—hypertension	1.94e-05	0.000174	CcSEcCtD
Phenylephrine—Nausea—Irbesartan—hypertension	1.94e-05	0.000174	CcSEcCtD
Phenylephrine—Rash—Losartan—hypertension	1.94e-05	0.000174	CcSEcCtD
Phenylephrine—Dermatitis—Losartan—hypertension	1.94e-05	0.000173	CcSEcCtD
Phenylephrine—Headache—Losartan—hypertension	1.93e-05	0.000172	CcSEcCtD
Phenylephrine—Nausea—Hydrochlorothiazide—hypertension	1.92e-05	0.000172	CcSEcCtD
Phenylephrine—Urticaria—Lisinopril—hypertension	1.9e-05	0.00017	CcSEcCtD
Phenylephrine—Hypersensitivity—Timolol—hypertension	1.9e-05	0.00017	CcSEcCtD
Phenylephrine—Nausea—Furosemide—hypertension	1.89e-05	0.000169	CcSEcCtD
Phenylephrine—Nausea—Betaxolol—hypertension	1.87e-05	0.000168	CcSEcCtD
Phenylephrine—Pruritus—Ramipril—hypertension	1.87e-05	0.000167	CcSEcCtD
Phenylephrine—Nausea—Losartan—hypertension	1.83e-05	0.000164	CcSEcCtD
Phenylephrine—Pruritus—Timolol—hypertension	1.82e-05	0.000163	CcSEcCtD
Phenylephrine—Hypersensitivity—Lisinopril—hypertension	1.76e-05	0.000158	CcSEcCtD
Phenylephrine—Dizziness—Ramipril—hypertension	1.74e-05	0.000156	CcSEcCtD
Phenylephrine—Dizziness—Timolol—hypertension	1.7e-05	0.000153	CcSEcCtD
Phenylephrine—Pruritus—Lisinopril—hypertension	1.69e-05	0.000151	CcSEcCtD
Phenylephrine—Vomiting—Ramipril—hypertension	1.68e-05	0.00015	CcSEcCtD
Phenylephrine—Rash—Ramipril—hypertension	1.66e-05	0.000149	CcSEcCtD
Phenylephrine—Dermatitis—Ramipril—hypertension	1.66e-05	0.000149	CcSEcCtD
Phenylephrine—Headache—Ramipril—hypertension	1.65e-05	0.000148	CcSEcCtD
Phenylephrine—Vomiting—Timolol—hypertension	1.64e-05	0.000147	CcSEcCtD
Phenylephrine—Rash—Timolol—hypertension	1.62e-05	0.000145	CcSEcCtD
Phenylephrine—Dermatitis—Timolol—hypertension	1.62e-05	0.000145	CcSEcCtD
Phenylephrine—Headache—Timolol—hypertension	1.61e-05	0.000145	CcSEcCtD
Phenylephrine—Dizziness—Lisinopril—hypertension	1.58e-05	0.000142	CcSEcCtD
Phenylephrine—Nausea—Ramipril—hypertension	1.57e-05	0.00014	CcSEcCtD
Phenylephrine—Nausea—Timolol—hypertension	1.53e-05	0.000137	CcSEcCtD
Phenylephrine—Vomiting—Lisinopril—hypertension	1.52e-05	0.000136	CcSEcCtD
Phenylephrine—Rash—Lisinopril—hypertension	1.51e-05	0.000135	CcSEcCtD
Phenylephrine—Dermatitis—Lisinopril—hypertension	1.51e-05	0.000135	CcSEcCtD
Phenylephrine—Headache—Lisinopril—hypertension	1.5e-05	0.000134	CcSEcCtD
Phenylephrine—Nausea—Lisinopril—hypertension	1.42e-05	0.000127	CcSEcCtD
Phenylephrine—ADRA1D—Signaling Pathways—HIF1A—hypertension	2.47e-06	3.7e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AGT—hypertension	2.46e-06	3.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EDN1—hypertension	2.46e-06	3.69e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—hypertension	2.45e-06	3.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRB2—hypertension	2.44e-06	3.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL5—hypertension	2.44e-06	3.66e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—hypertension	2.42e-06	3.64e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—hypertension	2.42e-06	3.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CALM1—hypertension	2.42e-06	3.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCE—hypertension	2.41e-06	3.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LEP—hypertension	2.41e-06	3.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOE—hypertension	2.41e-06	3.61e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALOX5—hypertension	2.39e-06	3.58e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GLP1R—hypertension	2.39e-06	3.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CAV1—hypertension	2.39e-06	3.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LPL—hypertension	2.39e-06	3.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFA—hypertension	2.38e-06	3.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VAV3—hypertension	2.38e-06	3.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOA1—hypertension	2.38e-06	3.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—H2AFX—hypertension	2.37e-06	3.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RPS6KB1—hypertension	2.36e-06	3.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDGFRB—hypertension	2.36e-06	3.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KDR—hypertension	2.36e-06	3.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFBR2—hypertension	2.35e-06	3.52e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADCY5—hypertension	2.34e-06	3.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GNB3—hypertension	2.33e-06	3.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCG—hypertension	2.32e-06	3.48e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—hypertension	2.31e-06	3.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ITGB3—hypertension	2.3e-06	3.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCA—hypertension	2.3e-06	3.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AVP—hypertension	2.3e-06	3.44e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—YWHAZ—hypertension	2.28e-06	3.43e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RHOA—hypertension	2.28e-06	3.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—F2—hypertension	2.27e-06	3.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PRKCB—hypertension	2.27e-06	3.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FN1—hypertension	2.27e-06	3.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GNAS—hypertension	2.27e-06	3.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NGF—hypertension	2.26e-06	3.39e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SPP1—hypertension	2.26e-06	3.39e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3R1—hypertension	2.25e-06	3.38e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL8—hypertension	2.25e-06	3.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH1—hypertension	2.22e-06	3.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOB—hypertension	2.22e-06	3.33e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3R1—hypertension	2.21e-06	3.32e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NOS3—hypertension	2.21e-06	3.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTK2—hypertension	2.21e-06	3.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—hypertension	2.2e-06	3.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCR5—hypertension	2.2e-06	3.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCD—hypertension	2.2e-06	3.3e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALDH2—hypertension	2.19e-06	3.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EDN1—hypertension	2.18e-06	3.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL5—hypertension	2.17e-06	3.25e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—hypertension	2.15e-06	3.23e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—C3—hypertension	2.15e-06	3.22e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—hypertension	2.13e-06	3.2e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HBA1—hypertension	2.13e-06	3.2e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LPL—hypertension	2.12e-06	3.18e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP11A1—hypertension	2.12e-06	3.18e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—H2AFX—hypertension	2.1e-06	3.16e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypertension	2.1e-06	3.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFRB—hypertension	2.1e-06	3.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RPS6KB1—hypertension	2.1e-06	3.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDGFB—hypertension	2.09e-06	3.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGFR1—hypertension	2.08e-06	3.12e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC9A1—hypertension	2.08e-06	3.12e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTT1—hypertension	2.08e-06	3.12e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADCY5—hypertension	2.07e-06	3.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—POMC—hypertension	2.07e-06	3.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCG—hypertension	2.06e-06	3.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INS—hypertension	2.06e-06	3.09e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCLC—hypertension	2.05e-06	3.08e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CETP—hypertension	2.05e-06	3.08e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HIF1A—hypertension	2.05e-06	3.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ITGB3—hypertension	2.05e-06	3.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCA—hypertension	2.05e-06	3.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AGT—hypertension	2.04e-06	3.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—YWHAZ—hypertension	2.03e-06	3.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL2—hypertension	2.02e-06	3.04e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—hypertension	2.02e-06	3.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NGF—hypertension	2.01e-06	3.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SPP1—hypertension	2.01e-06	3.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CALM1—hypertension	2.01e-06	3.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOE—hypertension	2e-06	3e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LEP—hypertension	2e-06	3e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—hypertension	2e-06	3e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—hypertension	1.99e-06	2.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT2—hypertension	1.99e-06	2.98e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CAV1—hypertension	1.98e-06	2.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—hypertension	1.98e-06	2.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOA1—hypertension	1.98e-06	2.97e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP17A1—hypertension	1.97e-06	2.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KDR—hypertension	1.96e-06	2.94e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCR5—hypertension	1.95e-06	2.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCD—hypertension	1.95e-06	2.93e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ENO1—hypertension	1.95e-06	2.92e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS1—hypertension	1.95e-06	2.92e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hypertension	1.92e-06	2.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—hypertension	1.91e-06	2.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—C3—hypertension	1.91e-06	2.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SERPINE1—hypertension	1.89e-06	2.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FN1—hypertension	1.89e-06	2.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCB—hypertension	1.89e-06	2.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—F2—hypertension	1.89e-06	2.83e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CTGF—hypertension	1.87e-06	2.81e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMGCR—hypertension	1.86e-06	2.79e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GOT2—hypertension	1.86e-06	2.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFB—hypertension	1.86e-06	2.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGFR1—hypertension	1.85e-06	2.77e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH1—hypertension	1.85e-06	2.77e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.83e-06	2.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGF2—hypertension	1.83e-06	2.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RHOA—hypertension	1.82e-06	2.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HIF1A—hypertension	1.82e-06	2.73e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ADRA2A—hypertension	1.82e-06	2.73e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AGT—hypertension	1.81e-06	2.72e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOS3—hypertension	1.8e-06	2.71e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3R1—hypertension	1.8e-06	2.71e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CALM1—hypertension	1.78e-06	2.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LEP—hypertension	1.78e-06	2.66e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOE—hypertension	1.78e-06	2.66e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—hypertension	1.76e-06	2.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CAV1—hypertension	1.76e-06	2.64e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOA1—hypertension	1.76e-06	2.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KDR—hypertension	1.74e-06	2.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—POMC—hypertension	1.72e-06	2.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INS—hypertension	1.71e-06	2.56e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TH—hypertension	1.7e-06	2.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RELA—hypertension	1.7e-06	2.55e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CALM2—hypertension	1.7e-06	2.55e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—EP300—hypertension	1.68e-06	2.53e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL2—hypertension	1.68e-06	2.52e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.68e-06	2.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—F2—hypertension	1.67e-06	2.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FN1—hypertension	1.67e-06	2.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCB—hypertension	1.67e-06	2.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTOR—hypertension	1.67e-06	2.5e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC2A4—hypertension	1.66e-06	2.48e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCG—hypertension	1.66e-06	2.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—hypertension	1.65e-06	2.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT2—hypertension	1.65e-06	2.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—hypertension	1.64e-06	2.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH1—hypertension	1.64e-06	2.46e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GOT1—hypertension	1.6e-06	2.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—hypertension	1.6e-06	2.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SERPINE1—hypertension	1.57e-06	2.35e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—STK11—hypertension	1.56e-06	2.34e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP19A1—hypertension	1.56e-06	2.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—hypertension	1.55e-06	2.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—POMC—hypertension	1.53e-06	2.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—hypertension	1.52e-06	2.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGF2—hypertension	1.52e-06	2.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INS—hypertension	1.52e-06	2.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RHOA—hypertension	1.51e-06	2.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3R1—hypertension	1.5e-06	2.25e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOS3—hypertension	1.5e-06	2.25e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL2—hypertension	1.49e-06	2.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—hypertension	1.47e-06	2.2e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT2—hypertension	1.47e-06	2.2e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.46e-06	2.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—hypertension	1.46e-06	2.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—hypertension	1.45e-06	2.17e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—COMT—hypertension	1.45e-06	2.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1A—hypertension	1.44e-06	2.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—hypertension	1.44e-06	2.16e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARGC1A—hypertension	1.43e-06	2.14e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNB3—hypertension	1.43e-06	2.14e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—hypertension	1.42e-06	2.13e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RELA—hypertension	1.41e-06	2.12e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—hypertension	1.41e-06	2.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—hypertension	1.4e-06	2.11e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CAT—hypertension	1.4e-06	2.1e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	1.39e-06	2.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SERPINE1—hypertension	1.39e-06	2.09e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNAS—hypertension	1.39e-06	2.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTOR—hypertension	1.38e-06	2.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EP300—hypertension	1.37e-06	2.06e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOB—hypertension	1.36e-06	2.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF2—hypertension	1.35e-06	2.02e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RHOA—hypertension	1.34e-06	2.02e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SRC—hypertension	1.33e-06	2e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3R1—hypertension	1.33e-06	2e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOS3—hypertension	1.33e-06	2e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—hypertension	1.33e-06	1.99e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—hypertension	1.32e-06	1.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—hypertension	1.3e-06	1.95e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LPL—hypertension	1.3e-06	1.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—hypertension	1.28e-06	1.93e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ADCY5—hypertension	1.27e-06	1.91e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPX1—hypertension	1.27e-06	1.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—hypertension	1.26e-06	1.9e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PRKCA—hypertension	1.26e-06	1.88e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—hypertension	1.26e-06	1.88e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RELA—hypertension	1.25e-06	1.88e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CD36—hypertension	1.23e-06	1.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTOR—hypertension	1.23e-06	1.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—hypertension	1.2e-06	1.8e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1A—hypertension	1.2e-06	1.8e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—hypertension	1.2e-06	1.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—hypertension	1.19e-06	1.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—hypertension	1.19e-06	1.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—hypertension	1.18e-06	1.77e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—hypertension	1.17e-06	1.76e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—hypertension	1.17e-06	1.76e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—hypertension	1.17e-06	1.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—hypertension	1.17e-06	1.75e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARA—hypertension	1.15e-06	1.72e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—hypertension	1.14e-06	1.71e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EP300—hypertension	1.14e-06	1.71e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—hypertension	1.12e-06	1.68e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AGT—hypertension	1.11e-06	1.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SRC—hypertension	1.11e-06	1.66e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CALM1—hypertension	1.09e-06	1.64e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOE—hypertension	1.09e-06	1.63e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CAV1—hypertension	1.08e-06	1.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—hypertension	1.08e-06	1.62e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA1—hypertension	1.08e-06	1.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—hypertension	1.07e-06	1.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1A—hypertension	1.06e-06	1.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—hypertension	1.06e-06	1.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—hypertension	1.04e-06	1.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—hypertension	1.04e-06	1.55e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—hypertension	1.02e-06	1.53e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EP300—hypertension	1.01e-06	1.52e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—hypertension	9.93e-07	1.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—hypertension	9.9e-07	1.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SRC—hypertension	9.84e-07	1.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—hypertension	9.82e-07	1.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—hypertension	9.71e-07	1.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—hypertension	9.59e-07	1.44e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—hypertension	9.49e-07	1.42e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—POMC—hypertension	9.36e-07	1.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—INS—hypertension	9.31e-07	1.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—hypertension	8.99e-07	1.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—hypertension	8.82e-07	1.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—hypertension	8.8e-07	1.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—hypertension	8.63e-07	1.29e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—hypertension	8.53e-07	1.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—hypertension	8.3e-07	1.24e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3R1—hypertension	8.16e-07	1.22e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NOS3—hypertension	8.16e-07	1.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—hypertension	8.15e-07	1.22e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—hypertension	7.46e-07	1.12e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—hypertension	7.46e-07	1.12e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—hypertension	7.24e-07	1.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—hypertension	6.89e-07	1.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—hypertension	6.63e-07	9.95e-06	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—hypertension	6.51e-07	9.77e-06	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—EP300—hypertension	6.21e-07	9.31e-06	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—hypertension	6.12e-07	9.18e-06	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—hypertension	3.75e-07	5.63e-06	CbGpPWpGaD
